Literature DB >> 1617166

Immunity and immunopathology in dengue virus infections.

I Kurane1, F E Ennis.   

Abstract

Dengue virus infections are a serious public health problem in tropical and subtropical areas of the world. Based on epidemiological data, it has been postulated that immune responses to dengue virus contribute to the pathogenesis of severe dengue illness, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Host immune responses are also important for controlling dengue virus infection. Therefore, dengue virus infections are an interesting model to explore the interactions between viruses and the immune system which result in immunopathology or recovery from infection. In this paper, we review immune responses to dengue viruses with an emphasis on the human T cell responses, and discuss possible roles of these immune responses in the control of dengue virus infection and in the pathogenesis of DHF/DSS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617166

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  45 in total

1.  Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses.

Authors:  E Wang; H Ni; R Xu; A D Barrett; S J Watowich; D J Gubler; S C Weaver
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

3.  Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.

Authors:  A Mathew; I Kurane; S Green; H A Stephens; D W Vaughn; S Kalayanarooj; S Suntayakorn; D Chandanayingyong; F A Ennis; A L Rothman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Virus replication and cytokine production in dengue virus-infected human B lymphocytes.

Authors:  Yu-Wen Lin; Kuan-Ju Wang; Huan-Yao Lei; Yee-Shin Lin; Trai-Ming Yeh; Hsiao-Sheng Liu; Ching-Chuan Liu; Shun-Hua Chen
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: Implications for early diagnosis and serotyping of dengue virus infections.

Authors:  Hua Xu; Biao Di; Yu-xian Pan; Li-wen Qiu; Ya-di Wang; Wei Hao; Li-juan He; Kwok-yung Yuen; Xiao-yan Che
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.

Authors:  Anna P Durbin; Maria José Vargas; Kimberli Wanionek; Samantha N Hammond; Aubree Gordon; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

7.  Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.

Authors:  Kathryn A Hanley; Mathilde Guerbois; Tiffany F Kautz; Meredith Brown; Stephen S Whitehead; Scott C Weaver; Nikos Vasilakis; Preston A Marx
Journal:  Am J Trop Med Hyg       Date:  2014-08-04       Impact factor: 2.345

8.  2nd International external quality control assessment for the molecular diagnosis of dengue infections.

Authors:  Cristina Domingo; Matthias Niedrig; Anette Teichmann; Marco Kaiser; Leonid Rumer; Richard G Jarman; Oliver Donoso-Mantke
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

9.  Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone.

Authors:  I Kurane; L C Dai; P G Livingston; E Reed; F A Ennis
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Dengue virus selectively induces human mast cell chemokine production.

Authors:  Christine A King; Robert Anderson; Jean S Marshall
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.